Lighthouse Investment Partners LLC Buys New Holdings in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Lighthouse Investment Partners LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCFree Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor bought 300,000 shares of the company’s stock, valued at approximately $3,039,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. K2 Principal Fund L.P. acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $1,945,000. Shaolin Capital Management LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $5,478,000. Finally, AQR Arbitrage LLC acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the 4th quarter valued at about $19,743,000.

Oaktree Acquisition Corp. III Life Sciences Price Performance

OACC stock opened at $10.47 on Wednesday. Oaktree Acquisition Corp. III Life Sciences has a 52-week low of $9.95 and a 52-week high of $10.85. The company’s 50-day moving average is $10.21.

Oaktree Acquisition Corp. III Life Sciences Company Profile

(Free Report)

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.

See Also

Want to see what other hedge funds are holding OACC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCFree Report).

Institutional Ownership by Quarter for Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)

Receive News & Ratings for Oaktree Acquisition Corp. III Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oaktree Acquisition Corp. III Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.